435-000.000 CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY
435-001.100 
DIFFERENTIATED TISSUE OR ORGAN OTHER THAN BLOOD, PER SE, OR
DIFFERENTIATED TISSUE OR ORGAN MAINTAINING; COMPOSITION THEREFOR
435-001.200 . Including perfusion; composition therefor
435-001.300 . Including freezing; composition therefor
435-002.000 MAINTAINING BLOOD OR SPERM IN A PHYSIOLOGICALLY ACTIVE STATE OR
COMPOSITIONS THEREOF OR THEREFOR OR METHODS OF IN VITRO BLOOD CELL
435-003.000 CONDITION RESPONSIVE CONTROL PROCESS
435-004.000 MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS;
COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH
435-005.000 . Involving virus or bacteriophage
435-006.000 . Involving nucleic acid
435-007.100 . Involving antigen-antibody binding, specific binding protein assay
or specific ligand-receptor binding assay
435-007.200 . . Involving a micro-organism or cell membrane bound antigen or cell
membrane bound receptor or cell membrane bound antibody or
435-007.210 . . . Animal cell
435-007.220 . . . . Parasite or protozoa
435-007.230 . . . . Tumor cell or cancer cell
435-007.240 . . . . Leukocyte (e.g., lymphocyte, granulocyte, monocyte, etc.)
435-007.250 . . . . Erythrocyte
435-007.300 . . . Flagellar-antigen or pili-antigen
435-007.310 . . . Fungi (e.g., yeast, mold, etc.)
435-007.320 . . . Bacteria or actinomycetales
435-007.330 . . . . Staphylococcus
435-007.340 . . . . Streptococcus
435-007.350 . . . . Salmonella
435-007.360 . . . . Sexually transmitted disease (e.g., chlamydia, syphilis,
435-007.370 . . . . Escherichia coli
435-007.400 . . To identify an enzyme or isoenzyme
435-007.500 . . Involving avidin-biotin binding
435-007.600 . . Involving a modified enzyme (e.g., abzyme, recombinant, chemically
altered, etc.)
435-007.700 . . Assay in which a label present is an apoenzyme, prosthetic group,
or enzyme cofactor
435-007.710 . . Assay in which a label present is an enzyme inhibitor or functions
to alter enzyme activity
435-007.720 . . Assay in which a label present is an enzyme substrate or substrate
435-007.800 . . Involving nonmembrane bound receptor binding or protein binding
other than antigen-antibody binding
435-007.900 . . Assay in which an enzyme present is a label
435-007.910 . . . Enzyme produces product which is part of another reaction system
(e.g., cyclic reaction, cascade reaction, etc.)
435-007.920 . . . Heterogeneous or solid phase assay system (e.g., ELISA, etc.)
435-007.930 . . . . Competitive assay
435-007.940 . . . . Sandwich assay
435-007.950 . . . . Indirect assay
435-008.000 . Involving luciferase
435-009.000 . Geomicrobiological testing (e.g., for petroleum, etc.)
435-010.000 . Involving uric acid
435-011.000 . Involving cholesterol
435-012.000 . Involving urea or urease
435-013.000 . Involving blood clotting factor (e.g., involving thrombin,
thromboplastin, fibrinogen, etc.)
435-014.000 . Involving glucose or galactose
435-015.000 . Involving transferase
435-016.000 . . Involving transaminase
435-017.000 . . Involving creatine phosphokinase
435-018.000 . Involving hydrolase
435-019.000 . . Involving esterase
435-020.000 . . . Involving cholinesterase
435-021.000 . . . Involving phosphatase
435-022.000 . . Involving amylase
435-023.000 . . Involving proteinase
435-024.000 . . Involving peptidase
435-025.000 . Involving oxidoreductase
435-026.000 . . Involving dehydrogenase
435-027.000 . . Involving catalase
435-028.000 . . Involving peroxidase
435-029.000 . Involving viable micro-organism
435-030.000 . . Methods of sampling or inoculating or spreading a sample; methods
of physically isolating an intact micro-organism
435-031.000 . . Testing for sterility condition
435-032.000 . . Testing for antimicrobial activity of a material
435-033.000 . . . Using multifield media
435-034.000 . . Determining presence or kind of micro-organism; use of selective
435-035.000 . . . Using radioactive material
435-036.000 . . . Streptococcus; staphylococcus
435-037.000 . . . Nitrate to nitrite reducing bacteria
435-038.000 . . . Enterobacteria
435-039.000 . . . Quantitative determination
435-040.000 . . . . Using multifield media
435-040.500 . Involving fixed or stabilized, nonliving microorganism, cell, or
tissue (e.g., processes of staining, stabilizing, dehydrating,
etc.; compositions used therefore, etc.)
435-040.510 . . Involving a monolayer, smear or suspension of microorganisms or
435-040.520 . . Involving tissue sections
435-041.000 MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO
SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION
435-042.000 . Process involving micro-organisms of different genera in the same
process, simultaneously
435-043.000 . Preparing compound having a 1-thia-4-aza-bicyclo (3.2.0) heptane
ring system (e.g., penicillin, etc.)
435-044.000 . . By desacylation of the substituent in 6-position
435-045.000 . . By acylation of the substituent in 6-position
435-046.000 . . In presence of phenyl acetic acid or phenyl acetamide or their
435-047.000 . Preparing compound having a 1-thia-5-aza-bicyclo (4.2.0) octane
ring system (e.g., cephalosporin, etc.)
435-048.000 . . Di-substituted in 7-position
435-049.000 . . Cephalosporin C
435-050.000 . . By acylation of the substituent in the 7-position
435-051.000 . . By desacylation of the substituent in the 7-position
435-052.000 . Preparing compound containing a cyclopentanohydrophenanthrene
nucleus; nor-, homo-, or D-ring lactone derivatives thereof
435-053.000 . . Containing heterocyclic ring
435-054.000 . . Acting on D-ring
435-055.000 . . . Acting at 17-position
435-056.000 . . . . Hydroxylating at 17-position
435-057.000 . . . Hydroxylating at 16-position
435-058.000 . . Hydroxylating
435-059.000 . . . At 11-position
435-060.000 . . . . At 11 alpha position
435-061.000 . . Dehydrogenating; dehydroxylating
435-062.000 . . . Forming an aryl ring from "A" ring
435-063.000 . Preparing compound containing a prostaglandin nucleus
435-064.000 . Preparing compound other than saccharide containing a tetracycline
nucleus (e.g., naphacene, etc.)
435-065.000 . Preparing compound other than saccharide containing a gibberellin
nucleus (i.e., gibbane)
435-066.000 . Preparing compound other than saccharide containing alloxazine or
isoalloxazine nucleus
435-067.000 . Preparing compound containing a carotene nucleus (i.e., carotene)
435-068.100 . Enzymatic production of a protein or polypeptide (e.g., enzymatic
hydrolysis, etc.)
435-069.100 . Recombinant DNA technique included in method of making a protein
435-069.200 . . Enzyme inhibitors or activators
435-069.300 . . Antigens
435-069.400 . . Hormones and fragments thereof
435-069.500 . . Lymphokines or monokines
435-069.510 . . . Interferons
435-069.520 . . . Interleukins
435-069.600 . . Blood proteins
435-069.700 . . Fusion proteins or polypeptides
435-069.800 . . Signal sequence (e.g., beta-galactosidase, etc.)
435-069.900 . . . Yeast derived
435-070.100 . Using tissue cell culture to make a protein or polypeptide
435-070.200 . . Fused or hybrid cells
435-070.210 . . . Producing monoclonal antibody
435-070.300 . . Animal tissue cell culture
435-070.400 . . . Blood (lymphoid) cell culture
435-070.500 . . . . Producing interferons
435-071.100 . Using a micro-organism to make a protein or polypeptide
435-071.200 . . Procaryotic micro-organism
435-071.300 . . . Antibiotic or toxin
435-072.000 . Preparing compound containing saccharide radical
435-073.000 . . Preparing S-glycoside (e.g., lincomycin, etc.)
435-074.000 . . Preparing O-glycoside (e.g., glucosides, etc.)
435-075.000 . . . Oxygen of the saccharide radical is directly bonded to a
nonsaccharide heterocyclic ring or a fused- or bridged-ring system
which contains a nonsaccharide heterocyclic ring (e.g.,
435-076.000 . . . . The hetero ring has eight or more ring members and only oxygen as
ring hetero atoms (e.g., erythromycin, spiramycin, nystatin, etc.)
435-077.000 . . . Oxygen atom of the saccharide radical is directly linked through
only acyclic carbon atoms to a nonsaccharide heterocyclic ring
(e.g., bleomycin, phleomycin, etc.)
435-078.000 . . . Oxygen atom of the saccharide radical is directly bonded to a
condensed ring system having three or more carboxyclic rings
(e.g., dauomycin, adriamycin, etc.)
435-079.000 . . . Oxygen atom of the saccharide radical is bonded to a cyclohexyl
radical (e.g., kasugamycin, etc.)
435-080.000 . . . . Cyclohexyl radical is substituted by two or more nitrogen atoms
(e.g., destomycin, neamin, etc.)
435-081.000 . . . . . Cyclohexyl radical is attached directly to a nitrogen atom of two
or more N-C(=N)-N radicals (e.g., streptomycin, etc.)
435-082.000 . . . . . Having two saccharide radicals bonded through only oxygen to
adjacent ring carbons of the cyclohexyl radical (e.g.,
435-083.000 . . . . . . Containing three or more saccharide radicals (e.g., liquidomycin,
neomycin, lividomycin, etc.)
435-084.000 . . Preparing nitrogen-containing saccharide
435-085.000 . . . N-glycoside
435-086.000 . . . . Cobalamin (i.e., vitamin B12, LLD factor)
435-087.000 . . . . Nucleoside
435-088.000 . . . . . Having a fused ring containing a six-membered ring having two
N-atoms in the same ring (e.g., purine nucleosides, etc.)
435-089.000 . . . . Nucleotide
435-090.000 . . . . . Dinucleotide (e.g., NAD, etc.)
435-091.100 . . . . . Polynucleotide (e.g., nucleic acid, oligonucleotide, etc.)
435-091.200 . . . . . . Acellular exponential or geometric amplification (e.g., PCR, etc.)
435-091.210 . . . . . . . Involving the making of multiple RNA copies
435-091.300 . . . . . . Polynucleotide contains only ribonucleotide monomers
435-091.310 . . . . . . . Involving catalytic ribonucleic acid
435-091.320 . . . . . . . Prepared from virus, prokaryotic acid
435-091.330 . . . . . . . . Involving virus
435-091.400 . . . . . . Modification or preparation of a recombinant DNA vector
435-091.410 . . . . . . . By insertion or addition of one or more nucleotides
435-091.420 . . . . . . . Involving deletion of a nucleotide or nucleotides from a vector
435-091.500 . . . . . . Acellular preparation of polynucleotide
435-091.510 . . . . . . . Involving RNA as a starting material or intermediate
435-091.520 . . . . . . . Involving a ligase (6.)
435-091.530 . . . . . . . Involving a hydrolase (3.)
435-092.000 . . . . . Having a fused ring containing a six-membered ring having two
N-atoms in the same ring (e.g., purine based mononucleotides,
435-093.000 . . Mashing or wort making
435-094.000 . . Produced by the action of an isomerase (e.g., fructose by the
action of xylose isomerase on glucose, etc.)
435-095.000 . . Produced by the action of a beta-amylase (e.g., maltose by the
action of beta-amylase on amylose, etc.)
435-096.000 . . Produced by the action of an exo-1.4 alpha glucosidase (e.g.,
dextrose by the action of glucoamylase on starch, etc.)
435-097.000 . . Produced by the action of a glycosyl transferase (e.g., alpha,
beta, gamma-cyclodextrins by the action of glycosyl transferase on
435-098.000 . . Produced by the action of an alpha-1, 6-glucosidase (e.g., amylose
debranched amylopectin by the action of pullulanase, etc.)
435-099.000 . . Produced by the action of a carbohydrase (e.g., maltose by the
action of alpha amylase on starch, etc.)
435-100.000 . . Disaccharide
435-101.000 . . Polysaccharide of more than five saccharide radicals attached to
each other by glycosidic bonds
435-102.000 . . . Pullulan
435-103.000 . . . Dextran
435-104.000 . . . Xanthan; i.e., xanthomonas-type heteropolysaccharides
435-105.000 . . Monosaccharide
435-106.000 . Preparing alpha or beta amino acid or substituted amino acid or
435-107.000 . . Proline; hydroxyproline; histidine
435-108.000 . . Tryptophan; tyrosine; phenylalanine; 3,4 dihydroxyphenylalanine
435-109.000 . . Aspartic acid (asparaginic acid); asparagine
435-110.000 . . Glutamic acid; glutamine
435-111.000 . . . Utilizing biotin or its derivatives
435-112.000 . . . Utilizing surfactant fatty acids or fatty acid esters (i.e.,
having seven or more atoms)
435-113.000 . . Methionine; cysteine; cystine
435-114.000 . . Citrulline; arginine; ornithine
435-115.000 . . Lysine; diaminopimelic acid; threonine; valine
435-116.000 . . Alanine; leucine; isoleucine; serine; homoserine
435-117.000 . Preparing heterocyclic carbon compound having only O, N, S, Se, or
Te as ring hetero atoms
435-118.000 . . Containing two or more hetero rings
435-119.000 . . . Containing at least two hetero rings bridged or fused among
themselves or bridged or fused with a common carbocyclic ring
435-120.000 . . Nitrogen or oxygen hetero atom and at least one other diverse
hetero ring atom in the same ring
435-121.000 . . Nitrogen as only ring hetero atom
435-122.000 . . . Containing six-membered hetero ring
435-123.000 . . Oxygen as only ring hetero atom
435-124.000 . . . Containing a hetero ring of at least seven ring members (e.g.,
zearalenone, macrocyclic lactones, etc.)
435-125.000 . . . Containing six-membered hetero ring (e.g., fluorescein, etc.)
435-126.000 . . . Containing five-membered hetero ring (e.g., griseofulvin, etc.)
435-127.000 . Preparing compound containing at least three carbocyclic rings
435-128.000 . Preparing nitrogen-containing organic compound
435-129.000 . . Amide (e.g., chloramphenicol, etc.)
435-130.000 . Preparing sulfur-containing organic compound
435-131.000 . Preparing organic compound containing a metal or atom other than
H, N, C, O, or halogen
435-132.000 . Preparing oxygen-containing organic compound
435-133.000 . . Containing quinone nucleus (i.e., quinoid structure)
435-134.000 . . Fat; fatty oil; ester-type wax; higher fatty acid (i.e., having at
least seven carbon atoms in an unbroken chain bound to a carboxyl
group); oxidized oil or fat
435-135.000 . . Carboxylic acid ester
435-136.000 . . Containing a carboxyl group
435-137.000 . . . Sugar acid having five or more carbon atoms (i.e., aldonic,
keto-aldonic, or saccharic acid)
435-138.000 . . . . Alpha-ketogulonic acid (i.e., 2-ketogulonic acid)
435-139.000 . . . Lactic acid
435-140.000 . . . Acetic acid
435-141.000 . . . Propionic or butyric acid
435-142.000 . . . Polycarboxylic acid
435-143.000 . . . . Having keto group (e.g., alpha-ketoglutaric acid, etc.)
435-144.000 . . . . Tricarboxylic acid (e.g., citric acid, etc.)
435-145.000 . . . . Dicarboxylic acid having four or less carbon atoms (e.g., fumaric,
maleic, etc.)
435-146.000 . . . Hydroxy carboxylic acid
435-147.000 . . Containing carbonyl group
435-148.000 . . . Ketone
435-149.000 . . . . Cyclopentanone or cyclopentadione containing compound
435-150.000 . . . . Acetone containing product
435-151.000 . . . . . Substrate contains grain or cereal material
435-152.000 . . . . . Substrate contains protein as nitrogen source
435-153.000 . . . . . Substrate contains inorganic nitrogen source
435-154.000 . . . . . Substrate contains inorganic compound, other than water
435-155.000 . . Containing hydroxy group
435-156.000 . . . Aromatic
435-157.000 . . . Acyclic
435-158.000 . . . . Polyhydric
435-159.000 . . . . . Glycerol
435-160.000 . . . . Butanol
435-161.000 . . . . Ethanol
435-162.000 . . . . . Multiple stages of fermentation; multiple types of micro-organisms
or reuse of micro-organisms
435-163.000 . . . . . Produced as by-product, or from waste, or from cellulosic material
435-164.000 . . . . . . Substrate contains sulphite waste liquor or citrus waste
435-165.000 . . . . . . Substrate contains cellulosic material
435-166.000 . Preparing hydrocarbon
435-167.000 . . Only acyclic
435-168.000 . Preparing element or inorganic compound except carbon dioxide
435-169.000 . Using actinomycetales
435-170.000 . Using bacteria
435-171.000 . Using fungi
435-440.000 PROCESS OF MUTATION, CELL FUSION, OR GENETIC MODIFICATION
435-441.000 . Mutation employing a chemical mutagenic agent
435-442.000 . . By replacement of standard nucleic acid base with base analog
(e.g., 5-bromouracil, etc.)
435-443.000 . . By use of intercalating agent (e.g., acridine orange, etc.)
435-444.000 . . By use of alkylating agent (e.g., nitrosoguanidine, etc.)
435-445.000 . . By use of oxidative deamination agent (e.g., nitrous acid, etc.)
435-446.000 . Mutation employing radiation or electricity
435-447.000 . . X-ray irradiation
435-448.000 . . Ultraviolet irradiation
435-449.000 . Fusion of cells
435-450.000 . . Employing electric current
435-451.000 . . One of the fusing cells is a human antibody-producing cell
435-452.000 . . One of the fusing cells is a mouse antibody-producing cell
435-453.000 . . One of the fusing cells is a plant cell
435-454.000 . . One of the fusing cells is a microorganism (e.g., prokaryote,
435-455.000 . Introduction of a polynucleotide molecule into or rearrangement of
nucleic acid within an animal cell
435-456.000 . . The polynucleotide is encapsidated within a virus or viral coat
435-457.000 . . . Helper virus is present
435-458.000 . . The polynucleotide is coated with or encapsulated within a lipid
containing material (e.g., liposome, etc.)
435-459.000 . . Involving particle-mediated transfection (i.e., biolistic
435-460.000 . . Involving laser treatment of the cell before or during
435-461.000 . . Involving electroporation
435-462.000 . . Involving site-specific recombination (e.g., Cre-lox, etc.)
435-463.000 . . Involving general or homologous recombination (e.g., gene
435-464.000 . . Involving gene duplication within the cell (e.g., amplification,
co-amplification, etc.)
435-465.000 . . Involving co-transfection
435-466.000 . . The polynucleotide is a shuttle vector or a transiently
replicating hybrid vector
435-467.000 . . Introducing an oncogene to establish a cell line
435-468.000 . Introduction of a polynucleotide molecule into or rearrangement of
a nucleic acid within a plant cell
435-469.000 . . Introduction via Agrobacterium
435-470.000 . . Introduction via electroporation, particle, fiber or
microprojectile mediated insertion, or injection
435-471.000 . Introduction of a polynucleotide molecule into or rearrangement of
nucleic acid within a microorganism (e.g., bacteria, protozoa,
435-472.000 . . The polynucleotide is encapsidated within a bacteriophage,
bacteriophage coat, or transducing particle
435-473.000 . . The polynucleotide contains a transposon
435-474.000 . . The polynucleotide is a cosmid
435-475.000 . . The polynucleotide is unencapsidated bacteriophage or viral
435-476.000 . . The polynucleotide is a plasmid or episome
435-477.000 . . . Plasmid or episome contains DNA targeting homologous recombination
to bacteriophage, viral, or chromosomal DNA within a microorganism
435-478.000 . . . Plasmid or episome contains at least part of a gene encoding a
restriction endonuclease or modification enzyme
435-479.000 . . . Plasmid or episome confers the ability to utilize directly a
compound which a wild type microorganism is unable to utilize
435-480.000 . . . Plasmid or episome contains at least part of a gene encoding a
toxin or encoding for virulence or pathogenicity
435-481.000 . . . Plasmid or episome contains a gene which complements a nutritional
deficiency mutation
435-482.000 . . . Plasmid or episome contains a gene which confers resistance to
metal, silicon, selenium, or tellurium toxicity
435-483.000 . . . Yeast is a host for the plasmid or episome
435-484.000 . . . Mycelial fungus is a host for the plasmid or episome
435-485.000 . . . Microorganism of the genus Bacillus is a host for the plasmid or
435-486.000 . . . Microorganism of the genus Streptomyces is a host for the plasmid
435-487.000 . . . Microorganism of the genus Brevibacterium or the genus
Corynebacterium is a host for the plasmid or episome
435-488.000 . . . Microorganism of the genus Escherichia is a host for the plasmid
435-489.000 . . . Plural nonidentical plasmids are introduced into a host
microorganism or culture thereof (e.g., plasmid is part of a
435-490.000 . . The polynucleotide is an unbranched linear fragment
435-173.100 TREATMENT OF MICRO-ORGANISMS OR ENZYMES WITH ELECTRICAL OR WAVE
ENERGY (E.G., MAGNETISM, SONIC WAVES, ETC.)
435-173.200 . Enzyme treated
435-173.300 . Modification of viruses (e.g., attenuation, etc.)
435-173.400 . Cell membrane or cell surface is target
435-173.500 . . Membrane permeability increased
435-173.600 . . . Electroporation
435-173.700 . . Lytic effect produced (e.g., disruption of cell membrane for
release of subcellular parts; e.g., nucleic acids, etc.)
435-173.800 . Metabolism of micro-organism enhanced (e.g., growth enhancement or
increased production of microbial product)
435-173.900 . Concentration, separation, or purification of micro-organisms
435-174.000 CARRIER-BOUND OR IMMOBILIZED ENZYME OR MICROBIAL CELL;
CARRIER-BOUND OR IMMOBILIZED CELL; PREPARATION THEREOF
435-175.000 . Multi-enzyme system
435-176.000 . Enzyme or microbial cell is immobilized on or in an inorganic
435-177.000 . Enzyme or microbial cell is immobilized on or in an organic
435-178.000 . . Carrier is carbohydrate
435-179.000 . . . Carbohydrate is cellulose or derivative thereof
435-180.000 . . Carrier is synthetic polymer
435-181.000 . . . Attached to the carrier via a bridging agent
435-182.000 . . . Enzyme or microbial cell is entrapped within the carrier (e.g.,
gel, hollow fibre)
435-183.000 ENZYME (E.G., LIGASES (6. ), ETC.), PROENZYME; COMPOSITIONS
THEREOF; PROCESS FOR PREPARING, ACTIVATING, INHIBITING,
435-184.000 . Enzyme inactivation by chemical treatment
435-185.000 . Malt
435-186.000 . Pancreatin
435-187.000 . Preparing granular- or free-flowing enzyme composition
435-188.000 . Stablizing an enzyme by forming a mixture, an adduct or a
composition, or formation of an adduct or enzyme conjugate
435-188.500 . Catalytic antibody
435-189.000 . Oxidoreductase (1. ) (e.g., luciferase)
435-190.000 . . Acting on CHOH group as donor (e.g., glucose oxidase, lactate
dehydrogenase (1.1))
435-191.000 . . Acting on nitrogen-containing compound as donor (1.2, 1.5, 1.7)
435-192.000 . . Acting on hydrogen peroxide as acceptor (1.11)
435-193.000 . Transferase other than ribonuclease (2.)
435-194.000 . . Transferring phosphorus containing group (e.g., kineases,
435-195.000 . Hydrolase (3. )
435-196.000 . . Acting on ester bond (3.1)
435-197.000 . . . Carboxylic ester hydrolase (3.1.1)
435-198.000 . . . . Triglyceride splitting (e.g., lipase, etc. (3.1.1.3))
435-199.000 . . . Ribonuclease (3.1.4)
435-200.000 . . Acting on glycosyl compound (3.2)
435-201.000 . . . Acting on alpha-1, 4-glucosidic bond, (e.g., hyaluronidase,
invertase, amylase, etc. (some 3.2.1))
435-202.000 . . . . Alpha-amylase, microbial source
435-203.000 . . . . . Fungal source
435-204.000 . . . . Alpha-amylase, plant source (3.2.1.1)
435-205.000 . . . . Glucoamylase (3.2.1.3)
435-206.000 . . . Acting on beta-1, 4 link between N-acetylmuramic acid and
2-acetylamino 2 deoxy-D-glucose (e.g., lysozyme, etc.)
435-207.000 . . . Acting on beta-galatose-glycoside bond (e.g., beta-galactosidase,
435-208.000 . . . Acting on alpha-galatose-glycoside bond (e.g.,
435-209.000 . . . Acting on beta-1, 4-glucosidic bond (e.g., cellulase, etc.
435-210.000 . . . Acting on alpha-1, 6-glucosidic bond (e.g., isoamylase,
435-211.000 . . . . Dextranase (3.2.1.11)
435-212.000 . . Acting on peptide bond (e.g., thromboplastin, leucine
amino-peptidase, etc., (3.4))
435-213.000 . . . Trypsin; chymotrypsin
435-214.000 . . . Thrombin
435-215.000 . . . Urokinase
435-216.000 . . . Streptokinase
435-217.000 . . . Plasmin (i.e., fibrinolysin)
435-218.000 . . . Elastase
435-219.000 . . . Proteinase
435-220.000 . . . . Derived from bacteria
435-221.000 . . . . . Bacteria is bacillus
435-222.000 . . . . . . Bacillus subtilus or bacillus lichenoformis
435-223.000 . . . . Derived from fungi
435-224.000 . . . . . From yeast
435-225.000 . . . . . From aspergillus
435-226.000 . . . . Derived from animal tissue (e.g., rennin, etc.)
435-227.000 . . Acting on carbon to nitrogen bond other than peptide bond (3.5)
435-228.000 . . . Acting on a linear amide linkage in linear amide
435-229.000 . . . . Asparaginase
435-230.000 . . . . Penicillin amidase
435-231.000 . . . Acting on amide linkage in cyclic amides (e.g., penicillinase,
435-232.000 . Lyase (4. )
435-233.000 . Isomerase (5. )
435-234.000 . . Glucose isomerase
435-235.100 VIRUS OR BACTERIOPHAGE, EXCEPT FOR VIRAL VECTOR OR BACTERIOPHAGE
VECTOR; COMPOSITION THEREOF; PREPARATION OR PURIFICATION THEREOF;
PRODUCTION OF VIRAL SUBUNITS; MEDIA FOR PROPAGATING
435-236.000 . Inactivation or attenuation; producing viral subunits
435-237.000 . . By serial passage of virus
435-238.000 . . By chemical treatment
435-239.000 . Recovery or purification
435-325.000 ANIMAL CELL, PER SE (E.G., CELL LINES, ETC.); COMPOSITION THEREOF;
PROCESS OF PROPAGATING, MAINTAINING OR PRESERVING AN ANIMAL CELL
OR COMPOSITION THEREOF; PROCESS OF ISOLATING OR SEPARATING AN
ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF PREPARING A
COMPOSITION CONTAINING AN ANIMAL CELL; CULTURE MEDIA THEREFORE
435-326.000 . Animal cell, per se, expressing immunoglobulin, antibody, or
435-327.000 . . Immunoglobulin or antibody is anti-idiotypic
435-328.000 . . Immunoglobulin or antibody is chimeric, mutated, or a recombined
hybrid (e.g., bifunctional, bispecific, rodent-human chimeric,
single chain, rFv, immunoglobuin fusion protein, etc.)
435-329.000 . . Immunoglobulin or antibody binds an oligosaccharide structure
other than nucleic acid
435-330.000 . . Immunoglobulin or antibody binds an expression product of a cancer
related gene or fragment thereof (e.g., oncogene, proto-oncogene,
435-331.000 . . Immunoglobulin or antibody binds a specifically identified amino
435-332.000 . . Immunoglobulin or antibody binds a microorganism or normal or
mutant component or product thereof (e.g., animal cell, cell
surface antigen, secretory product, etc.)
435-333.000 . . . Binds a nucleic acid or derivative or component thereof (e.g.,
DNA, RNA, DNA-RNA, hybrid, nucleotide, nucleoside, carcinogen-DNA
435-334.000 . . . Binds a receptor (e.g., transferrin receptor, Fc receptor,
dihydropyridine receptor, IL-2 receptor, etc.)
435-335.000 . . . Binds a lymphokine, cytokine, or other secreted growth regulatory
factor, differentiation factor, intercellular mediator specific
for a hematopoietic cell (e.g., interleukin, interferon,
435-336.000 . . . Binds a hormone or other secreted growth regulatory factor,
differentiation factor, intercellular mediator, or
neurotransmitter (e.g., insulin, human chorionic gonadotropin,
intragonadal regulatory protein, Mullerian inhibiting substance,
inhibin, epidermal growth factor, nerve growth factor, dopamine,
435-337.000 . . . Binds a plasma protein, serum protein, or fibrin (e.g., clotting
factor fibrinolytic factor, complement factor, immunoglobulin,
435-338.000 . . . Binds an enzyme
435-339.000 . . . Binds a virus or component or product thereof (e.g., virus
associated antigen, etc.)
435-339.100 . . . . Binds a retrovirus or component or product thereof (e.g., HIV,
435-340.000 . . . Binds a bacterium or similar microorganism or component or product
thereof (e.g., Streptococcus, Legionella, Mycoplasma, bacterium
associated antigen, exotoxin, etc.)
435-341.000 . . . Binds a fungus or plant cell or component or product thereof
(e.g., fungus associated antigen, etc.)
435-342.000 . . . Binds a parasitic protozoan or metazoan cell or component or
product thereof; (e.g., Dirofilaria, Eimeria, Coccidia,
Trichinella, parasite cell surface antigen, etc.)
435-343.000 . . . Binds a hematopoietic cell or component or product thereof (e.g.,
erythrocyte, granulocyte, macrophage, monocyte, platelet,
myelogenous leukemia cell, bone marrow stem cell, granulocytic
cell surface antigen, hemoglobin, thrombospondin, glycophorin,
435-343.100 . . . . Binds a lymphocytic or lymphocytic-like cell or component or
product thereof (e.g., B cell, B-lineage bone marrow cell, null
cell, natural killer cell, B-lymphoblastoid cell, B-lineage, acute
lymphoblastic leukemia cell, B-lymphocytic cell surface antigen,
435-343.200 . . . . . Binds a T-lymphocytic cell or component or product thereof (e.g.,
T-cell, thymocyte, T-lineage bone marrow cell, T-lymphoblastoid
cell, T-lineage acute lymphoblastic leukemia cell, T-lymphocytic
435-344.000 . . . Binds a cancer cell or component or product thereof (e.g., cell
surface antigen, etc.)
435-344.100 . . . . Binds an antigen characterized by name or molecular weight (e.g.,
CEA, NCA, CC glycoprotein, melanoma gp 150 antigen, etc.)
435-345.000 . . Immunoglobulin or antibody binds a drug, hapten, hapten-carrier
complex, or specifically identified chemical structure (e.g.,
435-346.000 . Fused or hybrid cell, per se
435-347.000 . Two or more cell types, per se, in co-culture
435-348.000 . Insect cell, per se
435-349.000 . Avian cell, per se
435-350.000 . Canine cell, per se
435-351.000 . Feline cell, per se
435-352.000 . Rodent cell, per se
435-353.000 . . Rat (i.e., Rattus)
435-354.000 . . Mouse (i.e., Mus)
435-355.000 . . . Blood or lymphatic origin or derivative
435-356.000 . . . L cell or derivative (e.g., Ltk(-), etc.)
435-357.000 . . . Fibroblast, fibroblast-like cell or derivative (e.g., NIH 3T3,
435-358.000 . . Chinese hamster ovary (i.e., CHO)
435-359.000 . . . Expressing recombinant tPA
435-360.000 . . . Expressing recombinant hormone or growth factor
435-361.000 . . . Expressing recombinant receptor
435-362.000 . . . Expressing recombinant antigen
435-363.000 . Primate cell, per se
435-364.000 . . Monkey kidney
435-365.000 . . . COS (e.g., COS-7, etc.)
435-365.100 . . . . Expressing recombinant lymphokine, interferon, hormone, growth
factor or morphogen
435-366.000 . . Human
435-367.000 . . . HeLa cell or derivative
435-368.000 . . . Nervous system origin or derivative
435-369.000 . . . Renal origin or derivative
435-370.000 . . . Hepatic origin or derivative
435-371.000 . . . Epithelial origin or derivative
435-372.000 . . . Blood, lymphatic, or bone marrow origin or derivative
435-372.100 . . . . Myeloma origin or derivative
435-372.200 . . . . B-cell or derivative
435-372.300 . . . . T-cell or derivative
435-373.000 . Method of co-culturing cells
435-374.000 . Method of storing cells in a viable state
435-375.000 . Method of regulating cell metabolism or physiology
435-376.000 . . Method of synchronizing cell division
435-377.000 . . Method of altering the differentiation state of the cell
435-378.000 . Method of detaching cells, digesting tissue or establishing a
435-379.000 . . Using mechanical means (e.g., trituration, etc.)
435-380.000 . . Releasing bound or adhered cell using protease
435-381.000 . . Digesting tissue with protease
435-382.000 . Method of culturing encapsulated cells
435-383.000 . Method of culturing cells in suspension
435-384.000 . . Culture medium contains a growth factor or growth regulator
435-385.000 . . . Medium contains a colony stimulating factor
435-386.000 . . . Medium contains an interleukin
435-387.000 . . . Medium contains a polypeptide hormone
435-388.000 . . Culture medium contains an albumin
435-389.000 . . Culture medium contains a transferrin
435-390.000 . . Culture medium contains an incompletely defined plant or microbial
extract excluding animal extract
435-391.000 . . Culture medium contains an animal extract
435-392.000 . . . Serum
435-393.000 . . Using airlift or laminar flow aeration or foam culture
435-394.000 . . Wherein culture vessel is rotated or oscillated or culture is
435-395.000 . Solid support and method of culturing cells on said solid support
435-396.000 . . Support is a resin
435-397.000 . . Support is a gel surface
435-398.000 . . Support is a fiber
435-399.000 . . . Fabric, mat, gauze, or fibrous coating
435-400.000 . . . Hollow
435-401.000 . . Support is a membrane
435-402.000 . . Support is a coated or treated surface
435-403.000 . . Support is a suspendable particle
435-404.000 . Culture medium, per se
435-405.000 . . Contains a growth factor or growth regulator
435-406.000 . . . Contains a polypeptide hormone
435-407.000 . . Contains an albumin
435-408.000 . . Contains an animal extract
435-410.000 PLANT CELL OR CELL LINE, PER SE (E.G., TRANSGENIC, MUTANT, ETC.);
COMPOSITION THEREOF; PROCESS OF PROPAGATING, MAINTAINING, OR
PRESERVING PLANT CELL OR CELL LINE; PROCESS OF ISOLATING OR
SEPARATING A PLANT CELL OR CELL LINE; PROCESS OF REGENERATING
PLANT CELLS INTO TISSUE, PLANT PART, OR PLANT, PER SE, WHERE NO
435-411.000 . Tomato cell or cell line, per se
435-412.000 . Corn cell or cell line, per se
435-413.000 . . Herbicide resistant
435-414.000 . Tobacco cell or cell line, per se
435-415.000 . Soybean cell or cell line, per se
435-416.000 . Sunflower cell or cell line, per se
435-417.000 . Potato cell or cell line, per se
435-418.000 . Plant cell or cell line, per se, is pest or herbicide resistant or
435-419.000 . Plant cell or cell line, per se, contains exogenous or foreign
435-420.000 . Culture, maintenance, or preservation techniques, per se
435-421.000 . . Involving protoplast
435-422.000 . . Involving conifer cell or tissue (e.g., pine, spruce, fir, cedar,
435-423.000 . . Involving tomato cell or tissue
435-424.000 . . Involving corn cell or tissue
435-425.000 . . Involving tobacco cell or tissue
435-426.000 . . Involving soybean cell or tissue
435-427.000 . . Involving cotton cell or tissue
435-428.000 . . Involving sunflower cell or tissue
435-429.000 . . Involving potato cell or tissue
435-430.000 . . Involving regeneration or propagation into a plant or plant part
435-430.100 . . . Involving callus or embryonic stage
435-431.000 . Medium, per se, for culture, maintenance, regeneration, etc.
435-242.000 SPORE FORMING OR ISOLATING PROCESS
435-243.000 MICRO-ORGANISM, PER SE (E.G., PROTOZOA, ETC.); COMPOSITIONS
THEREOF; PROCES OF PROPAGATING, MAINTAINING OR PRESERVING
MICRO-ORGANISMS OR COMPOSITIONS THEREOF; PROCESS OF PREPARING OR
ISOLATING A COMPOSITION CONTAINING A MICRO-ORGANISM; CULTURE MEDIA
435-244.000 . Chemical stimulation of growth or activity by addition of chemical
compound which is not an essential growth factor; stimulation of
growth by removal of a chemical compound
435-245.000 . Adaptation or attenuation of cells
435-246.000 . Foam culture
435-247.000 . Utilizing media containing lower alkanol (i.e., having one to six
435-248.000 . Utilizing media containing hydrocarbon
435-249.000 . . Aliphatic
435-250.000 . . . Having five or less carbon atoms
435-251.000 . Utilizing media containing waste sulphite liquor
435-252.000 . Utilizing media containing cellulose or hydrolysates thereof
435-252.100 . Bacteria or actinomycetales; media therefor
435-252.200 . . Rhizobium or agrobacterium
435-252.300 . . Transformants (e.g., recombinant DNA or vector or foreign or
exogenous gene containing, fused bacteria, etc.)
435-252.310 . . . Bacillus (e.g., B. subtilis, B. thuringiensis, etc.)
435-252.320 . . . Brevibacterium or corynebacterium
435-252.330 . . . Escherichia (e.g., E. coli, etc.)
435-252.340 . . . Pseudomonas
435-252.350 . . . Streptomyces
435-252.400 . . Mixed culture
435-252.500 . . Bacillus (e.g., B. subtilis, B. thuringiensis, etc.)
435-252.600 . . Actinoplanes
435-252.700 . . Clostridium
435-252.800 . . Escherichia (e.g., E. coli, etc.) or salmonella
435-252.900 . . Lactobacillus, pediococcus, or leuconostoc
435-253.100 . . Mycobacterium
435-253.200 . . Nocardia
435-253.300 . . Pseudomonas
435-253.400 . . Streptococcus
435-253.500 . . Streptomyces
435-253.600 . . Culture media, per se
435-254.100 . Fungi
435-254.110 . . Transformants
435-254.200 . . . Yeast; media therefor
435-254.210 . . . . Saccharomyces
435-254.220 . . . . Candida
435-254.230 . . . . Pichia
435-254.300 . . . Aspergillus
435-254.400 . . . Neurospora
435-254.500 . . . Penicillium
435-254.600 . . . Trichoderma
435-254.700 . . . Fusarium
435-254.800 . . . Mucor
435-254.900 . . . Rhizopus
435-255.100 . . Yeast
435-255.200 . . . Saccharomyces
435-255.210 . . . . Culture media, per se, or technique
435-255.300 . . . Cryptococcus
435-255.400 . . . Candida or torulopsis
435-255.500 . . . Pichia
435-255.600 . . . Hansenula
435-255.700 . . . Culture media, per se, or technique
435-256.100 . . Aspergillus
435-256.200 . . Mucor
435-256.300 . . Penicillium
435-256.400 . . Cephalosporium or acremonium
435-256.500 . . Fusarium
435-256.600 . . Rhizopus
435-256.700 . . Trichoderma
435-256.800 . . Culture media, per se, or technique
435-257.100 . Algae, media therefor
435-257.200 . . Transformants
435-257.300 . . Chlorella
435-257.400 . . Euglena
435-257.500 . . Scenedesmus
435-257.600 . . Chlamydomonas
435-258.100 . Protozoa, media therefor
435-258.200 . . Plasmodium
435-258.300 . . Leishmania
435-258.400 . . Eimeria
435-259.000 . Lysis of micro-organism
435-260.000 . Preserving or maintaining micro-organism
435-261.000 . Separation of micro-organism from culture media
435-320.100 VECTOR, PER SE (E.G., PLASMID, HYBRID PLASMID, COSMID, VIRAL
VECTOR, BACTERIOPHAGE VECTOR, ETC.) BACTERIOPHAGE VECTOR, ETC.)
435-262.000 PROCESS OF UTILIZING AN ENZYME OR MICRO-ORGANISM TO DESTROY
HAZARDOUS OR TOXIC WASTE, LIBERATE, SEPARATE, OR PURIFY A
PREEXISTING COMPOUND OR COMPOSITION THEREFORE; CLEANING OBJECTS OR
435-262.500 . Destruction of hazardous or toxic waste
435-263.000 . Textile treating
435-264.000 . Cleaning using a micro-organism or enzyme
435-265.000 . Depilating hides, bating, or hide treating using enzyme or
435-266.000 . Treating gas, emulsion, or foam
435-267.000 . Treating animal or plant material or micro-organism
435-268.000 . . Treating organ or animal secretion
435-269.000 . . Treating blood fraction
435-270.000 . . Removing nucleic acid from intact or disrupted cell
435-271.000 . . Glyceridic oil, fat, ester-type wax, or higher fatty acid
435-272.000 . . Proteinaceous material recovered or purified
435-273.000 . . . Collagen or gelatin
435-274.000 . . Carbohydrate material recovered or purified
435-275.000 . . . Pectin or starch
435-276.000 . . . Sugar (e.g., molasses treatment, etc.)
435-277.000 . . . Cellulose (e.g., plant fibers, etc.)
435-278.000 . . . . Producing paper pulp
435-279.000 . . . . Hemp or flax treating
435-280.000 . Resolution of optical isomers or purification of organic compounds
or composition containing same
435-281.000 . Petroleum oil or shale oil treating
435-282.000 . . Desulfurizing
435-283.100 APPARATUS
435-284.100 . Differentiated tissue (e.g., organ) perfusion or preservation
435-285.100 . Mutation or genetic engineering apparatus
435-285.200 . . With means for applying an electric current or charge (e.g.,
electrofusion, electroporation, etc.)
435-285.300 . . Including projectile means
435-286.100 . Including condition or time responsive control means
435-286.200 . . Including position control
435-286.300 . . . Plater, streaker, or spreader
435-286.400 . . . Including liquid dispenser means
435-286.500 . . Including liquid flow, level, or volume control
435-286.600 . . Including gas flow or pressure control
435-286.700 . . Including mixing or agitation control
435-287.100 . Including measuring or testing
435-287.200 . . Measuring or testing for antibody or nucleic acid, or measuring or
testing using antibody or nucleic acid
435-287.300 . . With sample or reagent mechanical transport means
435-287.400 . . Sterility testing means
435-287.500 . . Means for measuring gas pressure or gas volume of gas evolved from
or consumed in an enzymatic or microbial reaction
435-287.600 . . Including frangible means for introducing a sample or reagent
435-287.700 . . Including bibulous or absorbent layer
435-287.800 . . . Including multiple, stacked layers
435-287.900 . . Including a coated reagent or sample layer
435-288.100 . . Including a bottle, tube, flask, or jar
435-288.200 . . . Including multiple internal compartments or baffles
435-288.300 . . Including a dish, plate, slide, or tray
435-288.400 . . . Including multiple compartments (e.g., wells, etc.)
435-288.500 . . . . Including means for fluid passage between compartments (e.g.,
between wells, etc.)
435-288.600 . . Including column separation means
435-288.700 . . Including optical measuring or testing means
435-289.100 . Bioreactor
435-290.100 . . Composting apparatus
435-290.200 . . . Including agitation means
435-290.300 . . . . Compostor is rotatably mounted
435-290.400 . . . Including solid or liquid transport means into or out of a
435-291.100 . . Malting or mashing apparatus
435-291.200 . . . Movable floor to facilitate maintenance (e.g., cleaning)